Ayunan, Ansar B.

HRN: 24 30 78  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/27/2023
01/02/2024
IV
4.5
Q6
Septicemia
Waiting Final Action 
12/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/27/2023
01/02/2024
IV
600mg
Q8
Sepsis Sec To Facial Abscess
Waiting Final Action 
01/03/2024
CLINDAMYCIN 300MG (CAP)
01/03/2024
01/09/2024
PO
300mg
Q8
Cellulitis Vs Abscess L Periorbital Area
Waiting Final Action 
01/03/2024
CO-AMOXICLAV 625MG (TAB)
01/03/2024
01/09/2024
PO
625mg
TID
Cellulitis Vs Abscess L Periorbital Area
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: